Position in EXEL
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$12,309
-$270 QoQ
Shares Held
287
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Wealth Management Group, LLC holds $371,669 across 55 Biotechnology names. EXEL ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
62 | $47,903 | |
| 2 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $42,300 | |
| 3 | INCY |
Incyte Corp
|
225 | $21,177 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
63 | $20,844 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
40 | $17,861 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
55 | $14,207 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
206 | $12,916 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
287 | $12,309 |
All Filings in EXEL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,309 | 287 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $12,579 | 287 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $11,853 | 287 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $12,650 | 287 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $10,596 | 287 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $9,557 | 287 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $7,447 | 287 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $6,448 | 287 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,918 | 123 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,686 | 112 | Shares | Sole | 2024-02-08 | |
| No filing history on record for this holder in this stock. | ||||||